- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 11.04. | TORL BioTherapeutics secures $158m for oncology pipeline development | ||
| 10.04. | Invenra, Astellas sign bispecific antibody discovery agreement | ||
| 09.04. | FDA approves ViiV Healthcare's Dovato for adolescent HIV treatment | ||
| 08.04. | US FDA grants breakthrough status to Dizal's sunvozertinib | ||
| 05.04. | Teva signs licensing deal with mAbxience for oncology biosimilar candidate | ||
| 04.04. | Alterome Therapeutics secures $132m in Series B funding | ||
| 03.04. | Bavarian Nordic announces commercial availability of mpox vaccine in US | ||
| 02.04. | Solid Biosciences' SGT-003 receives rare pediatric disease designation | ||
| 01.04. | US FDA grants orphan drug designation to Biostar Pharma's utidelone | ||
| 29.03. | FDA approves Gilead's Vemlidy sNDA for paediatric HBV patients | ||
| 28.03. | Santhera's vamorolone NDA receives priority review in China | ||
| 27.03. | Cipla enters deal to distribute Sanofi's CNS products in India | ||
| 26.03. | Q32 Bio concludes merger deal with Homology Medicines | ||
| 25.03. | EMA CHMP recommends marketing authorisation for Novartis' PNH treatment | ||
| 22.03. | FDA approves Italfarmaco's Duvyzat for DMD treatment | ||
| 21.03. | Evommune expands EVO756 collaboration with Maruho in Asia | ||
| 20.03. | Takeda gets approval for acute lymphoblastic leukemia treatment sNDA | ||
| 19.03. | AstraZeneca signs agreement to acquire Fusion Pharmaceuticals | ||
| 18.03. | FDA committee recommends BMS-2seventy's Abecma | ||
| 15.03. | Tubulis secures $138.8m to develop ADCs for solid tumours | ||
| 14.03. | FDA grants orphan drug status to Poseida's multiple myeloma therapy | ||
| 13.03. | Prilenia Therapeutics plans MAA submission to CHMP for pridopidine | ||
| 12.03. | Johnson & Johnson files sBLA for ulcerative colitis treatment | ||
| 11.03. | FDA approves Novo Nordisk's Wegovy for cardiovascular risk reduction | ||
| 08.03. | iOnctura receives orphan drug status for pancreatic cancer therapy |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
